RecruitingNot ApplicableNCT06416059

A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking

A Mobile-Delivered Personalized Feedback Intervention for Black Individuals Who Engage in Hazardous Drinking


Sponsor

University of Houston

Enrollment

50 participants

Start Date

May 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to develop and examine a culturally adapted, mobile health application for the Android and iOS platform. The application uses a personalized feedback intervention (PFI) designed to enhance knowledge regarding adverse anxiety-alcohol interrelations, increase motivation and intention to reduce hazardous drinking, and reduce positive attitudes and intention regarding anxiety-related alcohol use among Black hazardous drinkers with clinical anxiety.


Eligibility

Min Age: 21 Years

Inclusion Criteria6

  • Being 21 years of age or older
  • Self-identifying as Black or African American
  • Meeting criteria for current hazardous drinking pattern
  • Meeting criteria for clinical anxiety
  • Being able to provide written, informed consent
  • Owning a smartphone.

Exclusion Criteria6

  • Current participation in alcohol or other substance abuse treatment
  • Engaged in psychotherapy for anxiety or depression
  • Concurrent use of medication for anxiety or depression
  • Being pregnant by self-report
  • Residence outside of the United States confirmed via survey geolocation
  • Inability to provide a valid United States-issued driver's license or identification card to verify identity.

Interventions

BEHAVIORALMobile Application

The mobile application is a culturally adapted, brief, personalized feedback intervention (PFI) to address alcohol misuse in the context of clinical anxiety,


Locations(1)

RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06416059


Related Trials